The compact and symmetric structure of rosmarinic acid (Table 1) binds specifically to Aβ, inhibits polymerization into the fibrillar form, and inhibits tau aggregation [170,173], imparting protection in AD and other neurogenerative conditions. Here, MAPT is linked to Alzheimer disease.